Elarex Inc.
PrivateLast Round
Grant
Sep 1, 2022
Total Funding Raised
$1.08M
Company Overview
Elarex Inc. operates in Healthcare & Life Sciences and is based in Burlington. Its latest recorded funding round was a Grant round in September 2022.
Elarex Inc. is a biotechnology company that develops proprietary stabilization technology to improve the temperature stability of vaccines and biologic drugs, aiming to eliminate the need for cold-chain transportation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Pharma Supply Chain
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Elarex Inc. Comparables
Compare Elarex Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Inaedis Inc. | 88% | |
| EnsiliTech | 87% | |
| Jurata Thin Film | 87% |
For institutional investors. Book with your work email.
Elarex Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 1, 2022 | ||||
| Grant | Nov 4, 2021 |
For institutional investors. Book with your work email.
Elarex Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gates Foundation | Grant |
| National Research Council Canada Industrial Research Assistance Program | Seed |
| National Research Council of Canada | Grant |
| Ontario Centre of Innovation | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 2, 2025
Monthly visitors grew 9511% MoM, from 9 to 865.
- Dec 4, 2023
Grew 43% QoQ, from 7 to 10 employees.
For institutional investors. Book with your work email.
Elarex Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Elarex Inc.'s valuation, stock price, and market status.
Is Elarex Inc. a public or private company?
Elarex Inc. is a private company.
What is the current stock price of Elarex Inc.?
Elarex Inc. is a private company, so its shares have no public market price. Caplight tracks Elarex Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Elarex Inc. worth (valuation)?
Valuation information for Elarex Inc. is not publicly available.
Can I buy Elarex Inc. stock?
Elarex Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Elarex Inc.'s last funding round?
Elarex Inc.'s most recent funding round was Grant on September 1, 2022.
Who are the main investors in Elarex Inc.?
Key investors in Elarex Inc. include Gates Foundation, National Research Council Canada Industrial Research Assistance Program, National Research Council of Canada, Ontario Centre of Innovation.
Will Elarex Inc. IPO soon?
No public IPO plans have been announced for Elarex Inc..
How can I track Elarex Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Elarex Inc.'s shares on secondary markets.